Cargando…
Hypoalbuminemia in patients following their recovery from severe coronavirus disease 2019
Coronavirus disease 2019 (COVID‐19) is caused by a contagious virus that has spread to more than 200 countries, territories, and regions. Thousands of studies to date have examined all aspects of this disease, yet little is known about the postrecovery status of patients, especially in the long term...
Autores principales: | Ali, Kameran M., Ali, Ayad M., Tawfeeq, Hassan M., Figueredo, Grazziela P., Rostam, Hassan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250600/ https://www.ncbi.nlm.nih.gov/pubmed/33830538 http://dx.doi.org/10.1002/jmv.27002 |
Ejemplares similares
-
Clinical laboratory parameters and comorbidities associated with severity of coronavirus disease 2019 (COVID-19) in Kurdistan Region of Iraq
por: Ali, Hussein Noori, et al.
Publicado: (2022) -
Serum troponin, D‐dimer, and CRP level in severe coronavirus (COVID‐19) patients
por: Ali, Ayad M., et al.
Publicado: (2021) -
Disease severity and efficacy of homologous vaccination among patients infected with SARS‐CoV‐2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers
por: Ali, Ayad M., et al.
Publicado: (2022) -
SARS-CoV-2 reinfection in patients negative for immunoglobulin G following recovery from COVID-19
por: Ali, A.M., et al.
Publicado: (2021) -
A new biomarker in severe pneumonia associated with coronavirus disease 2019: hypoalbuminemia. A prospective study
por: Otal, Yavuz, et al.
Publicado: (2022)